10.15 
Main targets for stroke prevention until 2050 - the epidemiologist´s point of view | Peter Heuschmann, Würzburg

10.30-12.00 
Heart and Brain
Crosstalk between Brain and Heart – implications for the clinician | Matthias Endres, Berlin
Breakthrough strokes – in search of solutions for a neglected condition | David Seiffge, Bern
A rational approach to the search for AF after stroke and TIA | Rolf Wachter, Leipzig
Should we get stroke patients with AF back into sinus rhythm | Kars Neven, Essen
Left atrial appendage – To close or not to close? | Karl-Georg Häusler, Ulm

12.00 
Short Bio Break

12.15-13.15 
Cerebral Small Vessel Disease
Pathophysiological insights that will change our approach to Cerebral Small vessel disease | Hugh Markus, Cambridge
Developing new therapies for cerebral arteriosclerotic small vessel disease | Martin Dichgans, München
Perspectives for a better treatment of Cerebral Amyloid Angiopathy  | Andreas Charidimou, Boston

13.15 
Lunch Break

14.00 
Acute Ischemic stroke – Hot stuff 
State of the Art: Thrombolysis and Thrombectomy | Urs Fischer, Bern
Ongoing recanalization trials | Götz Thomalla, Hamburg
Moving the frontiers: New techniques in interventional neuroradiology | Rene Chapot, Essen
What´s in the pipeline - trials beyond recanalization | Christos Krogias, Herne
Debate: Prehospital stroke care in metropolitan areas should include Mobile Stroke Units | Pro: Lucio D´Anna, London; Con: Martin Köhrmann, Essen

15.30 
Coffee Break

16.00 -17.15 
Stroke Prevention – Atherosclerosis 
Managing stenosing atherosclerotic disease – how I choose between surgery, intervention and medical management | Peter Ringleb, Heidelberg
How to approach non-stenosing vulnerable carotid Plaques? | Anna Kopczak, München
New approaches for preventing atherosclerotic stroke | Pierre Amarenco, Paris

17.15-17.45 
Special lecture 
Managing TIAs – Past, Present and Future | Peter Rothwell, Oxford

18.30-19.15 
Evening lecture
Metal and Fire at Krupp - A hard rocking history of severe stroke treatment | Werner Hacke, Heidelberg

 

10.45-11.15 
Coffee Break

11.15-12.15 
Innovations: Part 1 New Meds on the block – Developing approaches for stroke prevention
Antithrombotics | Roland Veltkamp, Essen
Lipid lowering therapy | Georgios Ntaios, Thessaloniki
Antidiabetics | Waltraud Pfeilschifter, Lüneburg

12.15-13.15 
Innovations: Part 2 Quo vadis – visions for the future
Developing drugs using genetics | Dipender Gill, London
How can blood-based biomarkers guide stroke prevention? | Joan Montaner, Seville
How will Artificial Intelligence alter everyday work in the Clinical Neurosciences? | Michael Forsting, Essen

13.15 
Summary and Adjourn

Further information    registration | organisational matters | program | speakers and moderators